Synergy Spine Solutions, which focuses on cervical disc replacement devices, closed $30 million in series A financing.
The financing was led by Amzak Health, according to a Jan. 31 news release. Money will go towrd the company's investigational device exemption 2-level clinical trial. The trial will evaluate the disc at two contiguous levels compared to anterior cervical discectomy and fusion.
Through the investment Joyce Erony of Amzak Health also joined Synergy's board of directors.